LinkedIn Profile

Access New Health Sciences historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:newhealthsciences 147147 May 30th, 2019 12:00AM New Health Sciences, Inc. 1.2K 13.00 Open Medical Devices May 30th, 2019 01:56PM May 30th, 2019 01:56PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Open Medical Devices, Medical Device R&D, Blood Management, Blood Products, Clinical Research, Blood Collection, Blood Storage, Medical Device Management, Transfusion Medicine, Biomechanical Innovation 245 First Street, Suite 1800 Cambridge MA US 02142 Health Care Equipment & Services
private:newhealthsciences 147147 Dec 16th, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 16th, 2017 02:21PM Dec 16th, 2017 02:21PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 17th, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 17th, 2017 08:12AM Dec 17th, 2017 08:12AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 18th, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 18th, 2017 10:19AM Dec 18th, 2017 10:19AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 19th, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 19th, 2017 05:03AM Dec 19th, 2017 05:03AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 21st, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 21st, 2017 12:42PM Dec 21st, 2017 12:42PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 22nd, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 22nd, 2017 05:53AM Dec 22nd, 2017 05:53AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 23rd, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 23rd, 2017 09:37AM Dec 23rd, 2017 09:37AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 24th, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 24th, 2017 01:22PM Dec 24th, 2017 01:22PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services
private:newhealthsciences 147147 Dec 25th, 2017 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Dec 25th, 2017 10:21AM Dec 25th, 2017 10:21AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.